Skip to main content
Clinical Trials/CTRI/2022/10/046547
CTRI/2022/10/046547
Not Yet Recruiting
Phase 3

EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHICMEDICINES IN TREATMENT OF DELUSIONAL DISORDER

DR L SAROJINI0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
DR L SAROJINI
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR L SAROJINI

Eligibility Criteria

Inclusion Criteria

  • Cases satisfying Delusional disorder (F22\) diagnostic criteria of DSM\-V,Age group between 18 to 70 years

Exclusion Criteria

  • Organic delusional disorder, Induced delusional disorder, or any other psychiatric
  • comorbidity.
  • Subjects who used psychotropic medicines in the past two weeks.
  • Subjects who are pregnant or lactating
  • Severe systemic illness using conventional treatment.
  • Immuno\-compromised conditions like HIV, Tuberculosis etc

Outcomes

Primary Outcomes

Not specified

Similar Trials